|
Volumn 68, Issue 2, 2009, Pages 296-
|
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biological: results from a 24-week multicentre randomised placedo-controlled trial (Annals of the Rheumatic Diseases (2008) 67 (1516-23))
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERRATUM;
ERROR;
PRIORITY JOURNAL;
|
EID: 58849108578
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: None Document Type: Erratum |
Times cited : (10)
|
References (0)
|